This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.

Deletion of short arm of chromosome 5 Deletion of short arm of chromosome 5 (Cri-du-chat syndrome)

Contents

No.ItemNo.ItemNo.Item
AClassification codes and basic information BSynonyms CAdult-onset considerations
1History 2Causes and genetics 3Epidemiology
4Pathogenesis and pathophysiology 5Clinical symptoms 6Clinical signs
7Screening 8Diagnosis 9Treatment
10Prognosis 11Complications and comorbidities 12Genetic counseling and prevention
13References

A. Classification codes and basic information

ICD-10 codeQ93.4
Special Copayment Reduction codeV205
Re-approval cycle5 years
Main name (Korean)Deletion of short arm of chromosome 5
Main name (English)Deletion of short arm of chromosome 5
NoteCri-du-chat syndrome; 5p15.2 deletion

B. Synonyms

Korean synonymsCri-du-chat syndrome
English synonymsCri-du-chat syndrome; Cat cry syndrome; 5p deletion syndrome; 5p- syndrome; Chromosome 5p deletion syndrome

C. Adult-onset considerations

Cri-du-chat syndrome is a congenital disorder with a characteristic phenotype from birth, but patients who survive into adulthood require ongoing management of intellectual disability, behavioral problems, and physical complications. In adulthood, aggressive behavior, stereotyped behavior, and sleep disturbances may become prominent, and management of secondary complications such as joint contractures, scoliosis, and obesity is a key task. Because fertility is mostly preserved, genetic counseling is important.


1. History

Cri-du-chat syndrome was first described in 1963 by the French cytogeneticist Jérôme Lejeune. Lejeune had already discovered trisomy 21 (Down syndrome) for the first time in 1959 and was leading research on the association between chromosomal abnormalities and clinical phenotypes. He noted that several children with a deletion of the short arm (short arm, p arm) of chromosome 5 shared a peculiar high-pitched cry in the neonatal period, and named it in French "cry of the cat (cri du chat)".

Lejeune's first report was published in 1963 in Comptes Rendus de l'Académie des Sciences, and the clinical features described at the time included low birth weight, microcephaly, facial dysmorphism, hypotonia, and intellectual disability. This report was the first case to prove that a chromosomal deletion is a direct cause of human disease, and it became a milestone in clinical cytogenetics.

In the 1960s–70s, the development of G-banding (Giemsa banding) precisely localized the deletion to 5p15, and it was shown that the size of the deletion correlates with the severity of the phenotype. In the 1980s, with the introduction of molecular genetic techniques, the deletion boundary regions were progressively mapped more precisely; in particular, deletion of the 5p15.2 region was identified as the key cause of the abnormal neonatal cry, and deletion of the 5p15.3 region as the main cause of intellectual disability.

Since the 1990s, with the introduction of fluorescence in situ hybridization (FISH) and chromosomal microarray (CMA), smaller deletions have become detectable, and research began on the roles of genes within the deleted region such as CTNND2 (catenin delta-2), TERT (telomerase reverse transcriptase), and the SEMAPHORIN gene family. Since the 2000s, comparative genomic hybridization (array CGH) has allowed precise quantification of deletion size, and genotype-phenotype correlation studies are actively under way. To date, data on thousands of patients have accumulated worldwide, greatly improving understanding of the clinical spectrum.

In Korea, with the introduction of cytogenetic testing in the 1970s, patients with cri-du-chat syndrome began to be reported sporadically. It is currently registered as eligible for the rare disease Special Copayment Reduction (V205), and ongoing medical support is provided through a 5-year re-approval system.


2. Causes and genetics

The cause of cri-du-chat syndrome is a partial deletion of the short arm of chromosome 5 (5p). Deletion size varies from 5p15.2–5p15.3 microdeletions to deletion of the entire short arm, and deletion size is directly related to clinical severity.

Deletion types and mechanisms

About 85–90% arise as de novo deletions, of which about 80% are of paternal origin and 20% of maternal origin. The remaining 10–15% arise from a structural chromosomal rearrangement in a parent (mainly a balanced translocation). A 5p deletion appears when an abnormal derivative chromosome is transmitted to a child from a parent who is a balanced translocation carrier. Patients of translocation origin may have additional chromosomal imbalances (such as concurrent trisomy), which can make the phenotype more complex.

Correlation between deletion size and phenotype

Deletion size ranges from about 5 Mb to more than 40 Mb. Deletion of the 5p15.2 region is associated with the high-pitched neonatal cry, and deletion of 5p15.3 causes more severe intellectual disability and language delay. In particular, the CTNND2 gene (5p15.2) is involved in synaptic plasticity and cognitive function, and haploinsufficiency of this gene has been proposed as the main cause of intellectual disability. The TERT gene (5p15.33) is related to cellular senescence, but the clinical significance of deletion of this gene alone is still under study.

Ring chromosome 5

Rarely, a ring chromosome 5 arises in which both ends are deleted. In this case, a 5q deletion accompanies the 5p deletion, and additional clinical abnormalities may appear. Ring chromosomes are unstable during cell division and readily become mosaic.

Mosaic form

Rarely, a mosaic form with a mixture of normal cells and 5p-deleted cells is reported. In the mosaic form, the phenotype is generally milder, and in some cases language and cognitive development are relatively good. Because diagnosis can be delayed when the mosaicism rate is low, many cells should be analyzed when there is clinical suspicion.


3. Epidemiology

Cri-du-chat syndrome is relatively frequent among chromosomal deletion syndromes. It is reported to occur worldwide at a frequency of 1 per 15,000–50,000 live births, and some literature estimates 1 per 25,000. The sex difference is minimal, but there are reports that it is slightly more frequent in girls.

It is relatively common among chromosomal deletions because the 5p terminal region has structurally unstable genetic characteristics. Thousands of new diagnoses are estimated worldwide each year, and patients registered with the US cri-du-chat syndrome society (5p- Society) alone number in the hundreds. Accurate statistics on prevalence in Korea are limited, but according to rare disease registry data, an estimated several dozen to several hundred patients are registered.

The prenatal diagnosis rate during pregnancy has been increasing since the introduction of fetal karyotyping and non-invasive prenatal testing (NIPT). When a 5p monosomy signal is detected on NIPT, invasive testing is needed for confirmation. Unlike trisomies, for which advanced maternal age is a risk factor, the effect of maternal age is not evident for de novo deletions. When one parent is a balanced translocation carrier, there is a risk of recurrence in the next pregnancy, so prior genetic counseling is important.


4. Pathogenesis and pathophysiology

The clinical phenotype caused by the 5p deletion is due to haploinsufficiency of the deleted genes. The key pathophysiologic mechanisms are as follows.

Abnormal neonatal cry (cri-du-chat)

The characteristic cat-like cry results from abnormal laryngeal development, with a combination of laryngomalacia, narrowing of the epiglottis, and abnormal vocal cord tissue. Deletion of the 5p15.2 region is most closely associated with this abnormality, and abnormal neurologic control also contributes. After the neonatal period, the cry tends to gradually normalize.

Intellectual disability and language delay

CTNND2 (p120-catenin, δ-catenin) is essential for neuronal migration, dendrite formation, and synaptic plasticity. Haploinsufficiency of this gene impairs the formation of synaptic connections in the hippocampus and cortex, with a decisive effect on learning, memory, and language development. The SEMA5A gene at 5p15.3 is also involved in axon guidance and affects neural circuit formation.

Microcephaly and abnormal brain development

The mechanism of microcephaly is presumed to be loss of genes regulating brain cell proliferation and differentiation. MRI findings reported include hypoplasia of the corpus callosum, cerebellar hypoplasia, and simplified gyral pattern. Many genes involved in neuronal migration pathways and cortical organization are located in the deleted region.

Hypotonia

Neonatal hypotonia is understood as central hypotonia due to abnormal central nervous system development. It is the main cause of early feeding difficulties, respiratory problems, and delayed developmental milestones. Muscle tone gradually normalizes with growth, but persists in some patients.


5. Clinical symptoms

The clinical phenotype of cri-du-chat syndrome varies with deletion size, but there are characteristic age-specific patterns from the neonatal period to adulthood.

Neonatal period and infancy

A peculiar high-pitched cry is the most characteristic early symptom; it is high in pitch, short, and similar to a cat's mewing. Low birth weight is common at birth, accompanied by feeding difficulty and vomiting. Because of hypotonia, motor development is delayed throughout infancy. Abnormal primitive reflexes, such as an abnormal Moro reflex, are observed.

Childhood

Language development is more severely delayed than motor development. Many children have no spoken words by age 2, and language comprehension tends to be better than expression. Behavioral patterns similar to autism spectrum disorder (repetitive behaviors, difficulty with social interaction) are observed in 30–40%. Hyperactivity and attention deficits are also common.

Adulthood

Intellectual disability ranges from mild to moderate-severe. In patients with limited language ability, aggressive behavior due to communication frustration may appear. Stereotyped behavior, self-injurious behavior, and anxiety symptoms may become prominent in adulthood. It is clinically noteworthy that many patients show a relatively sociable and friendly personality.


6. Clinical signs

Physical examination findings vary with deletion size and age, but there are characteristic patterns.

Craniofacial dysmorphism

Microcephaly is observed in most patients, with small head circumference from birth. Hypertelorism (increased distance between the eyes), epicanthal folds, downslanting palpebral fissures, a low nasal bridge, and retrognathia are characteristic. Ear malformations (low-set ears, auricular dysplasia) are also common. Facial features change with age and may look less typical in adulthood than in childhood.

Musculoskeletal system

Joint hypermobility is observed in association with hypotonia. Scoliosis may develop with growth, accompanied by joint contractures and flat feet. Hand and foot malformations reported include brachydactyly, syndactyly, and shortened limb length.

Cardiac malformations

Congenital heart defects are present in 30–50%. Ventricular septal defect (VSD) is the most common, and atrial septal defect (ASD), patent ductus arteriosus (PDA), and tetralogy of Fallot (TOF) are also reported. Cardiac malformations may require early surgical correction.


7. Screening

Currently, there is no general neonatal screening for cri-du-chat syndrome. However, non-invasive prenatal testing (NIPT) during pregnancy can detect chromosomal abnormalities including 5p deletions, and detection sensitivity is relatively good for large 5p deletions. However, a positive NIPT result must be confirmed by karyotyping or CMA via chorionic villus sampling (CVS) or amniocentesis.

When a neonate shows the characteristic high-pitched cry, hypotonia, microcephaly, and facial dysmorphism after birth, immediate cytogenetic testing is recommended. Testing is also performed in children presenting with developmental delay or intellectual disability when clinical signs are present. For assessment of developmental delay, neurodevelopmental screening tests such as the Bayley Scales of Infant Development (Bayley), the Vineland Social Maturity Scale, and language development assessment are performed regularly.


8. Diagnosis

Cytogenetic or molecular genetic testing is required for confirmation.

Karyotyping

The 5p deletion is confirmed by high-resolution G-banding karyotyping (650 bands or more). Large deletions (>5 Mb) can be detected by karyotyping, but microdeletions may be missed. Parental karyotyping is also performed to determine whether a parent is a balanced translocation carrier.

FISH (fluorescence in situ hybridization)

Microdeletions can be confirmed by FISH using probes specific for 5p15.2 or 5p15.3. It is used as a complement when abnormalities on karyotyping are unclear, and is useful for rapidly confirming the presence and size of a deletion.

Chromosomal microarray (CMA)

This is currently the method recommended as the first-tier diagnostic test. Array CGH or SNP arrays can determine the exact location and size of the deletion at the base-pair level. This allows genotype-phenotype correlation analysis and detection of other associated abnormalities. Accurate diagnosis is possible even when the deletion is smaller than 5 Mb.

MLPA (multiplex ligation-dependent probe amplification)

It can be used as a rapid, cost-effective confirmatory test in patients with a suspected 5p deletion. It is particularly useful when the deletion is small or mosaicism is suspected.


9. Treatment

There is currently no curative gene therapy for cri-du-chat syndrome, and treatment focuses on symptom management and rehabilitation.

Intensive neonatal support

When feeding difficulties are present, nutritional support such as nasogastric tube feeding or gastrostomy may be needed. With severe hypotonia, intensive monitoring for respiratory management is needed. When a congenital heart defect is present, the timing of surgery is decided in consultation with the cardiac surgery team.

Rehabilitation

Early intervention programs greatly improve prognosis. Physical therapy (PT) begins right after birth for hypotonia and delayed motor development. Speech therapy (ST) focuses on promoting language development and training in augmentative and alternative communication (AAC). Occupational therapy (OT) helps improve daily living skills and fine motor function.

Behavioral and educational support

Behavioral therapies such as applied behavior analysis (ABA) are effective in managing autism spectrum-like behaviors, aggression, and self-injurious behavior. Special education support through an individualized education program (IEP) is important. For severe behavioral problems, atypical antipsychotics such as risperidone may be used short term, but evidence on the safety of long-term use is limited.

Management of complications

If hearing loss is present, hearing aids or cochlear implantation are considered. Scoliosis is managed with bracing or surgical correction. If seizures are present, anticonvulsant treatment is given. When hypothyroidism is present, thyroid hormone replacement therapy is given.


10. Prognosis

The prognosis of cri-du-chat syndrome differs greatly depending on deletion size and the severity of associated abnormalities. Overall, survival is relatively good, and a normal life expectancy can be expected in the absence of serious complications such as congenital heart defects. However, infant mortality increases when serious congenital malformations are present.

Intellectual disability is present in almost all patients, most commonly mild to moderate, with a minority showing severe intellectual disability. With small deletions (particularly deletion of 5p15.2 only), intellectual disability may be mild, and some can live semi-independently with support. Language development is one of the areas with the poorest prognosis, and communication ability often remains very limited even in adulthood. Introduction of augmentative and alternative communication (AAC) contributes to improved quality of life. Patients who received early intensive rehabilitation show significantly better outcomes in language, social skills, and self-care ability than those who did not.


11. Complications and comorbidities

Various complications and comorbidities are observed in cri-du-chat syndrome. Active monitoring and early treatment improve prognosis.

Neurologic complications

Seizure disorders occur in about 10–15%. In addition to cognitive impairment associated with microcephaly, movement disorders (dystonia, chorea, etc.) are rarely reported. Sleep apnea tends to increase in adulthood.

Sensory organs

Hearing loss (conductive or mixed) is common, with recurrent otitis media contributing. Ophthalmologic problems such as refractive errors, strabismus, and nasolacrimal duct obstruction are also frequent. Regular hearing and vision assessments are recommended.

Gastrointestinal system

Gastroesophageal reflux disease (GERD) is common in infancy and is a risk factor for aspiration pneumonia. Constipation is also a common problem. In adulthood, there is a tendency toward obesity, requiring dietary management.

Musculoskeletal system

Scoliosis can progress into adulthood, requiring periodic imaging assessment. Joint contractures and hip dislocation are reported.


12. Genetic counseling and prevention

When cri-du-chat syndrome is diagnosed, genetic counseling should involve the whole family. The recurrence risk differs depending on the mechanism of occurrence.

For de novo deletions, the recurrence risk is low, at less than 1%. However, because of the possibility of germline mosaicism, prenatal diagnosis is recommended in the next pregnancy. When caused by a parental balanced translocation, the recurrence risk is considerably higher (10–50%) and depends on the type of translocation and its balanced state. Parental karyotyping must be performed for all confirmed patients.

For prenatal diagnosis, NIPT, or chorionic villus sampling (CVS, 10–13 weeks) or amniocentesis (15–20 weeks) followed by karyotyping or CMA, can be performed. Preimplantation genetic testing (PGT-S or PGT-SR), combined with in vitro fertilization (IVF), checks embryos for the 5p deletion before transfer and is an option available to parents who are balanced translocation carriers. Because most patients' own fertility is preserved, genetic counseling and prenatal diagnosis are also recommended when an adult patient plans a pregnancy.


13. References

  1. Lejeune J, Lafourcade J, Berger R, et al. Trois cas de délétion partielle du bras court d'un chromosome 5. C R Acad Sci. 1963;257:3098–3102. (original article)
  2. Mainardi PC, Perfumo C, Cali A, et al. Clinical and molecular characterisation of 80 patients with 5p deletion: genotype-phenotype correlations. J Med Genet. 2001;38(3):151–158. PMID: 11238681
  3. Gersh M, Goodart SA, Pasztor LM, et al. Evidence for a distinct region causing a cat-like cry in patients with 5p deletions. Am J Hum Genet. 1995;56(6):1404–1410. PMID: 7762571
  4. Nguyen LS, Lepleux M, Moutton S, et al. Profiling olfactory stem cells from living patients identifies miRNAs relevant for autism pathophysiology. Mol Autism. 2016;7:1. PMID: 26823978
  5. Zhang X, Snijders A, Segraves R, et al. High-resolution mapping of genotype-phenotype relationships in cri du chat syndrome using array comparative genomic hybridization. Am J Hum Genet. 2005;76(2):312–326. PMID: 15635506
  6. Overhauser J, Huang X, Gersh M, et al. Molecular and phenotypic mapping of the short arm of chromosome 5: sublocalization of the critical region for the cri-du-chat syndrome. Hum Mol Genet. 1994;3(2):247–252. PMID: 8004087
  7. Cornish KM, Bramble D. Cri du chat syndrome: genotype-phenotype correlations and recommendations for clinical management. Dev Med Child Neurol. 2002;44(7):494–497. PMID: 12162387
  8. Cerruti Mainardi P. Cri du chat syndrome. Orphanet J Rare Dis. 2006;1:33. PMID: 16953888. DOI: 10.1186/1750-1172-1-33
  9. Hills C, Moller JH, Finkelstein M, Lohr J, Schimmenti L. Cri du chat syndrome and congenital heart disease. Am J Med Genet A. 2006;140(22):2453–2458. PMID: 17041939
  10. Kristoffersson U, Heim S, Mandahl N, et al. Monosomy and trisomy of 5p in two siblings due to maternal pericentric inversion 5(p13q33). Clin Genet. 1987;32(3):167–171. PMID: 3677451